Safety and Tolerance Study of Alpha-Lactalbumin Enriched and Probiotic-Supplemented Infant Formula in Infants With Colic

PHASE3CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
GrowthColic
Interventions
OTHER

Modilac Dahlia 1

Infant formula used for non breastfed children with colic

OTHER

Modilac 1

Infant formula used for non breastfed children

Trial Locations (12)

59020

Groupe Hospitalier de l'Institut Catholique de Lille (GHICL), Lille

59223

Dr Locquet André, Roncq

75013

Dr COUPRIE Claire, Paris

75015

Dr RONZIER Monique, Paris

77100

Dr Christophe Grillon, Meaux

92100

Dr Brigitte Pacault, Boulogne-Billancourt

Dr Michel Dogneton, Boulogne-Billancourt

Dr Nassira Belaroussi Maamri, Boulogne-Billancourt

92130

Dr KALINDJIAN, Issy-les-Moulineaux

92160

Dr Francine Gressin-Cohen, Antony

92166

Hôpital privé d'Antony, Antony

93602

Hôpital Robert Ballanger, Aulnay-sous-Bois

All Listed Sponsors
lead

Sodilac

INDUSTRY

NCT00929292 - Safety and Tolerance Study of Alpha-Lactalbumin Enriched and Probiotic-Supplemented Infant Formula in Infants With Colic | Biotech Hunter | Biotech Hunter